3 Major Violations Expose Roche Diagnostics Shanghai to Regulatory Penalty
On May 13, 2025, public records from Qichacha revealed that Roche Diagnostics Products (Shanghai) Co., Ltd. has been officially penalized for three serious breaches of China’s occupational health laws.
According to the notice, Roche failed to provide workers with mandatory occupational health training, neglected to arrange health checks for employees in potentially hazardous roles, and withheld crucial information about occupational disease risks during the signing of labor contracts.
The violations are based on the Occupational Disease Prevention Law of the People’s Republic of China, which obligates employers to:
-
Conduct pre-employment and regular health and safety training
-
Offer medical screening for employees exposed to occupational hazards
-
Clearly disclose any potential workplace health risks and protections in the labor contract
Authorities cited Roche’s failure to comply with Article 33, 34, and 35 of the law, emphasizing the employer’s duty to inform and protect employees in environments involving potential exposure to hazardous substances or conditions.
The notice serves as a warning to multinational corporations operating in China that local compliance standards on workplace health and safety remain non-negotiable. As workplace risks come under increasing scrutiny, failure to meet legal obligations can result in both reputational damage and administrative penalties.
Details of the penalty and related documentation were attached in the administrative notice published through official channels. Roche has not yet made a public statement regarding the incident.
2026-09-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution
-
NHU and Sinopec Advance Liquid Methionine Project
-
BASF and Nihon Nohyaku Partner for Fruit Crop Protection in Japan
-
Symrise Opens New Production Unit in Granada to Ensure Safer Supply of Bio-Based Pentylene Glycol
-
Mitsubishi Gas Chemical Suspends Construction of MXDA Plant in the Netherlands
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Suave Brands and Elida Beauty Complete Merger to Form Personal Care Giant Evermark with Annual Retail Sales Near $1.9 Billion
-
Syensqo Launches AI-Developed Coffee Peptide for Scalp Care
-
Huafon Chemical Plans RMB 6.85 Billion Acquisition to Expand Its TPU and PU Resin Portfolio
-
Sichuan’s 120,000 Tons Approved, Shandong’s 500,000 Tons on the Way:Is Wanhua Chemical Set to “Break Through” the LFP Market?
Recommend Reading
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
Isoascorbic Acid: Uses and Safety
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Insufficient Cost and Demand Support; PTA Prices to Weaken
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization